Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.
Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.
Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.
Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.
Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.
Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.
Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.
['Sawifiah dân: damdawi lam']
['He website hi zirna leh hriattîrna atâna buatsaih a ni a, damdawi lam thurâwn emaw, mi thiamte rawngbâwlna emaw pêkna a ni lo.']
['He thuziakte hi natna emaw, hrisêlna emaw hriat nân emaw, enkawl nân emaw hman tûr a ni lo va, mahni damdawi lam thurâwn zawngtute chuan doctor thiam tak an râwn tûr a ni.']
['Zawhna chhânna siamtu neural net chu a bîk takin number-a chhûtna a nih hunah a dik lo hle tih hre rawh. Entîr nân, natna engemaw nei mi eng zât nge tih.']
['Damdawi lam dinhmun chungchângah i doctor emaw, mi thiam dang emaw hnên aṭanga thurâwn dîl reng ang che. He website-a i thil chhiar avânga doctor thiamte thurâwn ngaihthah emaw, dîlna pawh tlai emaw ngai suh. Damdawi lama harsatna i nei nia i hriat chuan 911-ah phone la, a nih loh leh rang taka damdawi in hnai berah kal rawh. He website leh a hmanna hian doctor leh damlo inkûngkaihna a siam lo. BioMedLib emaw, a hnathawkte emaw, he website-a mi tupawhin heta thu awmte leh a hmanna chungchângah hian chiang taka sawi emaw, sawi loh emaw, eng mah an sawi lo.']
['Thu tlûkna: copyright']
['Kum 1998-a Digital Millennium Copyright Act, 17 U.S.C. § 512 (DMCA) chuan Internet-a thil awmte chuan US copyright law hnuaia an dikna a bawhchhia nia ringtute tân dân a siam a.']
['Kan website leh kan rawngbâwlna nêna inkûngkaih thil engpawh hian i copyright a bawhchhia tih i rin tlat chuan, nang (a nih loh leh i agent) chuan chu thil chu paih tûr emaw, a hman theih loh tûra khuahkhirh tûr emaw tiin hriattîrna min thawn thei a ni.']
["Hrilhfiahna chu e-mail hmanga thawn tur a ni (e-mail address chu 'Contact' section-ah en rawh)."]
['DMCA chuan i thuziak diklo nia puhna hriattirna-ah chuan a hnuaia mi ang hian thuziak diklo nia puhna i siamna chu ziak tel ngei ngei tur a ni: (1) diklo nia i sawi chu a diklo nia i hriatna lehkhabu ziakna; (2) diklo nia i sawi chu a diklo nia i hriatna lehkhabu ziakna leh a hmun kan hriat theihna tura thuziak ziakna; (3) i biakpawhna tur, i address, phone number leh email address te; (4) i thil ziah chu diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna lehkhabu ziakna, a diklo nia i hriatna lehkhabu ziakna lehkhabu ziakna, a ni.']
['(5) Thu dik lo sawi hlauvin i hming ziakna, hriattîrna thute chu a dikzia leh i bawhchhiat nia sawi dikna chanvo humhim tûra thuneihna i nei tih i puan chhuahna;']
['Tin, (6) copyright neitu emaw, a aiawha thil ti tûra thuneihna neitu emaw kutziak emaw, electronic signature emaw a ni tûr a ni.']
['A chunga mi ang hian i thil dilna chu a chhan theih a ni.']
['Inbiak pawhna']
['Zawhna / rawtna nei chuan email min rawn thawn ang che.']
How to treat lung cancer?
The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.
Some common treatment options include:
1. Surgery: This is often the preferred treatment for early-stage lung cancer.
The surgeon removes the tumor and a small portion of healthy tissue around it.
2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.
It can be used alone or in combination with other treatments.
3. Chemotherapy: This treatment uses drugs to kill cancer cells.
It can be given intravenously or or orally, and is often used in combination with other treatments.
4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.
It is often used for advanced or metastatic lung cancer.
5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.
It is often used for advanced or metastatic lung cancer.
6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.
It is often used for early-stage lung cancer.
7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.
It is often used for early-stage lung cancer.
8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.
It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
